Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)
Hypertension

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Hypertension, Uncontrolled hypertension, High blood pressure, Uncontrolled high blood pressure, Untreated high blood pressure, Untreated hypertension, Essential hypertension
Eligibility Criteria
Inclusion criteria
Participants with essential hypertension:
- who are on single drug therapy
- who are newly diagnosed and not yet taking any drug therapy, or have not had any drug therapy for at least 2 weeks prior to entering study
- who have blood pressure readings of 90mmHg ≤ MSDBP < 110mmHg and 140mmHg ≤ MSSBP <180mmHg after 2 weeks wash-out for patients on single agent.
Randomization (Visit 3)
After dosing of amlodipine 5mg for 6 weeks, blood pressure readings are:
- 90mmHg ≤ MSDBP < 110mmHg and 140mmHg ≤ MSSBP < 180mmHg.
Exclusion criteria
- Participant with MSDBP ≥ 110mmHg or MSSBP ≥ 180mmHg.
- Participant currently taking ≥ 2 antihypertensive medications (note: fixed-dose combination medicine should be counted as the number of active ingredients).
- Participant with known secondary hypertension of any etiology.
- Participant with malignant hypertension or current evidence of impending or active malignant hypertension, including headache, papilledema, cardiac ischemia, or pulmonary congestion precipitated by elevated blood pressure.
- Participant with known intolerance, contraindication or hypersensitivity to any component of dihydropyridines, angiotensin II receptor blockers.
- Participant showing positive in pregnancy test, lactating woman, or woman who intends to get pregnant during the study period.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Losartan/amlodipine Treatment Arm
Amlodipine Treatment Arm
One combination tablet containing 100 mg losartan potassium and 5 mg amlodipine camsylate, orally, once daily, for 8 weeks. Participants will also receive 2 tablets of placebo for amlodipine 5mg orally, once daily for 8 weeks.
2 tablets each containing 5 mg amlodipine, orally, once daily, for 8 weeks. Participants will also receive 1 tablet of placebo for combination losartan/amlodipine orally, once daily for 8 weeks.